Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Axitinib is a potent, selective small-molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), primarily synthesized via advanced organic coupling processes. Its chemical structure is defined by the molecular formula C22H19ClN4O and CAS number 319460-85-0.
Application
- Pharmaceutical manufacturing for second-line treatment of advanced renal cell carcinoma.
- Research & Development as a targeted therapy agent in oncology clinical trials.
- API production for global distribution to specialized hospitals and clinics.
Precautions
Strictly adhere to GMP standards during handling; store under controlled conditions at 2-8°C. Avoid exposure to moisture and direct sunlight. Clinical use requires monitoring for hypertension and proteinuria.